Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) of the intervertebral disc is a specialized, highly hydrated scaffold that provides the spine with structural integrity and the ability to withstand mechanical loads. It is primarily composed of a dense network of type II collagen fibers, which provide tensile strength, and large proteoglycans like aggrecan, which create osmotic pressure to maintain hydration (Roughley, P. J., 2004, Spine). In degenerative disc disease, the homeostatic balance is lost as catabolic enzymes, including matrix metalloproteinases (MMPs) and ADAMTS, degrade these essential proteins, leading to disc height loss and pain (Urban, J. P., & Roberts, S., 2003, Lancet). Therapeutic strategies focus on regenerating the ECM by using growth factors such as Growth Differentiation Factor 5 (GDF-5) or Bone Morphogenetic Protein 7 (BMP-7) to stimulate resident cells to produce new matrix components (Sivan, S. S., et al., 2014, Arthritis Research & Therapy). Additionally, peptides like Link N are being explored for their potential to upregulate the synthesis of collagen and aggrecan. Successful restoration of the ECM is considered a primary goal for biological therapies aiming to treat chronic low back pain and reverse disc degeneration.
Promotion of proteoglycan and collagen synthesis via anabolic signaling and inhibition of proteolytic degradation by MMPs and ADAMTS.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix protein in the intervertebral disc (IVD ECM).